BioCardia, Inc.
BCDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -87.8% | -64.7% | 33.2% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -7,463.8% | -1,519.7% | -553.4% | 36.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13,679.3% | -2,423.5% | -874.2% | -1,238.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13,700% | -2,425.8% | -880.7% | -1,243.4% |
| EPS Diluted | -2.9 | -8.19 | -10.05 | -11.19 |
| % Growth | 64.6% | 18.5% | 10.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |